Top

Published in:

01-09-2017 | Gynecologic Endocrinology and Reproductive Medicine

Application of testosterone supplementation in semen to improve sperm motility in asthenozoospermic males

Authors: Isarin Thanaboonyawat, Panicha Chantrapanichkul, Somsin Petyim, Chidchanok Kaewjunun, Pitak Laokirkkiat, Roungsin Choavaratana

Published in: Archives of Gynecology and Obstetrics | Issue 3/2017

Abstract

Purpose

To evaluate the effect of different concentrations and durations of seminal testosterone supplementation upon the motility of sperm from asthenozoospermic males.

Methods

Semen was collected from 41 infertile men with asthenozoospermia. After liquefaction, 200 μL was extracted from each semen sample and divided equally into five groups for a negative control, a vehicle control, and three experimental portions mixed with 4.75, 7.75, and 17.75 nmol/L of testosterone, respectively. The sperm motility was evaluated at 5, 15, 30, and 45 min following the addition of testosterone. The supernatant from remaining samples were sent for testosterone assay. Sperm viability was also evaluated after 45 min.

Results

There was no difference in the number of samples in each group which showed a 20% improvement in sperm motility. Group 3 showed a significant retardation in the reduction of motility compared with Group 5 (P < 0.05). Semen samples with a final testosterone concentration of 4.51–10 nmol/L showed a significant improvement in sperm motility when measured 5 min after addition. In contrast, samples showing a rise in testosterone level above 10 nmol/L were associated with a reduction in both sperm motility and viability.

Conclusion

Despite sperm motility decreasing over time, supplementation of semen samples with 4.75 nmol/L of testosterone could delay such reduction. A final seminal testosterone concentration of 4.51–10 nmol/L appears to be optimal for the best sperm motility.

Petraglia F, Serour GI, Chapron C (2013) The changing prevalence of infertility. Int J Gynaecol Obstet 123(Suppl 2):S4–S8. doi:10.1016/j.ijgo.2013.09.005 CrossRefPubMed

Tuntiseranee P, Olsen J, Chongsuvivatwong V, Limbutara S (1998) Fecundity in Thai and European regions: results based on waiting time to pregnancy. Hum Reprod 13:471–477CrossRefPubMed

Jungwirth A, Giwercman A, Tournaye H, Diemer T, Kopa Z, Dohle G et al (2012) European Association of Urology guidelines on male infertility: the 2012 update. Eur Urol 62:324–332. doi:10.1016/j.eururo.2012.04.048 CrossRefPubMed

Fritz MA, Speroff L (2011) Male Infertility. In: Fritz MA, Speroff L (eds) Clinical gynecologic endocrinology and infertility. Wolters Kluwer Health, Philadelphia, pp 1249–1292

Luboshitzky R, Kaplan-Zverling M, Shen-Orr Z, Nave R, Herer P (2002) Seminal plasma androgen/oestrogen balance in infertile men. Int J Androl 25:345–351CrossRefPubMed

World Health Organization (2010) WHO laboratory manual for the examination and processing of human semen, 5th edn. World Health Organization, Geneva

Guzick DS, Overstreet JW, Factor-Litvak P, Brazil CK, Nakajima ST, Coutifaris C et al (2001) Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med 345:1388–1393. doi:10.1056/NEJMoa003005 CrossRefPubMed

Casper RF, Meriano JS, Jarvi KA, Cowan L, Lucato ML (1996) The hypo-osmotic swelling test for selection of viable sperm for intracytoplasmic sperm injection in men with complete asthenozoospermia. Fertil Steril 65:972–976CrossRefPubMed

Dimitriadou F, Rizos D, Mantzavinos T, Arvaniti K, Voutsina K, Prapa A et al (1995) The effect of pentoxifylline on sperm motility, oocyte fertilization, embryo quality, and pregnancy outcome in an in vitro fertilization program. Fertil Steril 63:880–886CrossRefPubMed

10.

Tournaye H, Van der Linden M, Van den Abbeel E, Devroey P, Van Steirteghem A (1993) Effect of pentoxifylline on implantation and post-implantation development of mouse embryos in vitro. Hum Reprod 8:1948–1954CrossRefPubMed

11.

Rybar R, Kopecka V, Prinosilova P, Markova P, Rubes J (2011) Male obesity and age in relationship to semen parameters and sperm chromatin integrity. Andrologia 43:286–291. doi:10.1111/j.1439-0272.2010.01057.x CrossRefPubMed

12.

Bonanno O, Romeo G, Asero P, Pezzino FM, Castiglione R, Burrello N et al (2016) Sperm of patients with severe asthenozoospermia show biochemical, molecular and genomic alterations. Reproduction 152:695–704. doi:10.1530/REP-16-0342 CrossRefPubMed

13.

Peluso G, Palmieri A, Cozza PP, Morrone G, Verze P, Longo N et al (2013) The study of spermatic DNA fragmentation and sperm motility in infertile subjects. Arch Ital urol Androl 85:8–13. doi:10.4081/aiua.2013.1.8 CrossRefPubMed

14.

Zhang X, Diao R, Zhu X, Li Z, Cai Z (2015) Metabolic characterization of asthenozoospermia using nontargeted seminal plasma metabolomics. Clin Chim Acta 450:254–261. doi:10.1016/j.cca.2015.09.001 CrossRefPubMed

15.

Morse HC, Horike N, Rowley MJ, Heller CG (1973) Testosterone concentrations in testes of normal men: effects of testosterone propionate administration. J Clin Endocrinol Metab 37:882–886. doi:10.1210/jcem-37-6-882 CrossRefPubMed

16.

McLachlan RI, O’Donnell L, Meachem SJ, Stanton PG, de Kretser DM, Pratis K et al (2002) Hormonal regulation of spermatogenesis in primates and man: insights for development of the male hormonal contraceptive. J Androl 23:149–162PubMed

17.

Zhou Q, Nie R, Prins GS, Saunders PT, Katzenellenbogen BS, Hess RA (2002) Localization of androgen and estrogen receptors in adult male mouse reproductive tract. J Androl 23:870–881PubMed

18.

Walker WH (2010) Non-classical actions of testosterone and spermatogenesis. Philos Trans R Soc Lond Ser B Biol Sci 365:1557–1569. doi:10.1098/rstb.2009.0258 CrossRef

19.

Solakidi S, Psarra AM, Nikolaropoulos S, Sekeris CE (2005) Estrogen receptors alpha and beta (ERalpha and ERbeta) and androgen receptor (AR) in human sperm: localization of ERbeta and AR in mitochondria of the midpiece. Hum Reprod 20:3481–3487. doi:10.1093/humrep/dei267 CrossRefPubMed

20.

Aquila S, Middea E, Catalano S, Marsico S, Lanzino M, Casaburi I et al (2007) Human sperm express a functional androgen receptor: effects on PI3K/AKT pathway. Hum Reprod 22:2594–2605. doi:10.1093/humrep/dem243 CrossRefPubMed

21.

Walker WH (2011) Testosterone signaling and the regulation of spermatogenesis. Spermatogenesis 1:116–120. doi:10.4161/spmg.1.2.16956 CrossRefPubMedPubMedCentral

22.

Shang Y, Myers M, Brown M (2002) Formation of the androgen receptor transcription complex. Mol Cell 9:601–610CrossRefPubMed

23.

Zhang Q, Bai Q, Yuan Y, Liu P, Qiao J (2010) Assessment of seminal estradiol and testosterone levels as predictors of human spermatogenesis. J Androl 31:215–220. doi:10.2164/jandrol.109.007609 CrossRefPubMed

24.

Chomsrimek N, Choktanasiri W, Wongkularb A, O-Prasertsawat P (2008) Effect of time between ejaculation and analysis on sperm motility. Thai J Obstet Gynaecol 16:109–114

25.

Mann T, Jones R, Sherins RJ (1980) Fructolysis in human spermatozoa under normal and pathological conditions. J Androl 1:229–233CrossRef

26.

Ren D, Navarro B, Perez G, Jackson AC, Hsu S, Shi Q et al (2001) A sperm ion channel required for sperm motility and male fertility. Nature 413:603–609. doi:10.1038/35098027 CrossRefPubMed

27.

Loux SC, Crawford KR, Ing NH, Gonzalez-Fernandez L, Macias-Garcia B, Love CC et al (2013) CatSper and the relationship of hyperactivated motility to intracellular calcium and pH kinetics in equine sperm. Biol Reprod 89:123. doi:10.1095/biolreprod.113.111708 CrossRefPubMed

Title: Application of testosterone supplementation in semen to improve sperm motility in asthenozoospermic males
Authors: Isarin Thanaboonyawat
Panicha Chantrapanichkul
Somsin Petyim
Chidchanok Kaewjunun
Pitak Laokirkkiat
Roungsin Choavaratana
Publication date: 01-09-2017
Publisher: Springer Berlin Heidelberg
Published in: Archives of Gynecology and Obstetrics / Issue 3/2017
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-017-4451-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Application of testosterone supplementation in semen to improve sperm motility in asthenozoospermic males

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2017

Anti-Mullerian hormone (AMH) and embryo quality assessed by time-lapse imaging (TLI): a cross-sectional observational study

Spontaneous rupture of infarcted leiomyoma into endometrial cavity in a perimenopausal woman

Maternal serum homocysteine and uterine artery Doppler as predictors of preeclampsia and poor placentation

Postoperative sexual functioning in total versus subtotal laparoscopic hysterectomy: what do women expect?

Melanoma arising in an ovarian cystic teratoma: a systematic review of presentation, treatment, and outcomes

Is there any relationship between adipocytokines and angiogenesis factors to address endothelial dysfunction and platelet aggregation in untreated patients with preeclampsia?